C07C49/643

USE OF SUBSTITUTED CYCLOPENTENONES AND CYCLOPENTANONES AS AROMA INGREDIENTS

The present invention relates to use of at least one compound of formula (I) as aroma ingredient. The compound of formula (I) is used to impart an aroma impression which is reminiscent of a sweet note, technical note, tobacco note, balsamic note, herbal note, fruity note, woody note, pine needle note, eucalyptus note, powdery note, or a combination of two or more notes to a composition and also enhancing and/or modifying the aroma of a composition. The present invention is further directed to a composition comprising compound of formula (I) and (i) at least one aroma chemical different from compound of formula (I) or (ii) at least one non-aroma chemical carrier, or (iii) both (i) and (ii).

USE OF SUBSTITUTED CYCLOPENTENONES AND CYCLOPENTANONES AS AROMA INGREDIENTS

The present invention relates to use of at least one compound of formula (I) as aroma ingredient. The compound of formula (I) is used to impart an aroma impression which is reminiscent of a sweet note, technical note, tobacco note, balsamic note, herbal note, fruity note, woody note, pine needle note, eucalyptus note, powdery note, or a combination of two or more notes to a composition and also enhancing and/or modifying the aroma of a composition. The present invention is further directed to a composition comprising compound of formula (I) and (i) at least one aroma chemical different from compound of formula (I) or (ii) at least one non-aroma chemical carrier, or (iii) both (i) and (ii).

METHODS OF MAKING MULTICYCLIC COMPOUNDS USING MULTICOMPONENT/TANDEM REACTION SEQUENCES

Disclosed herein are embodiments of multicyclic compounds and methods of making such compounds. The disclosed methods reduce step-counts in the synthesis of complex targets, while reducing costs and waste streams.

METHODS OF MAKING MULTICYCLIC COMPOUNDS USING MULTICOMPONENT/TANDEM REACTION SEQUENCES

Disclosed herein are embodiments of multicyclic compounds and methods of making such compounds. The disclosed methods reduce step-counts in the synthesis of complex targets, while reducing costs and waste streams.

Tricyclic compounds and process for preparation thereof

The present invention discloses tricyclic compounds of formula (I) or salt thereof and their process for synthesis. Further, the present invention relates to the use of these novel tricyclic compounds of formula (I) or salt thereof as insect repellents. ##STR00001##

Tricyclic compounds and process for preparation thereof

The present invention discloses tricyclic compounds of formula (I) or salt thereof and their process for synthesis. Further, the present invention relates to the use of these novel tricyclic compounds of formula (I) or salt thereof as insect repellents. ##STR00001##

Curcusone diterpenoids and uses thereof

The present disclosure provides the first asymmetric total synthesis and target identification of the curcusone natural products. The novel convergent synthesis is built upon a cheap and abundant chiral pool molecule (8) and features a thermal [3,3]-sigmatropic rearrangement and an FeCl3-promoted global hydrolysis/adol condensation cascade to rapidly construct the critical cycloheptadienone core. By performing chemoproteomics with the alkyne probe 37, we identified the previously undruggable oncogenic protein BRAT1 as a key cellular target of 1d. Furthermore, 1d inhibits BRAT1 in cancer cells, thereby reducing cancer cell migration, increasing susceptibility to DNA damage, and inducing chemosensitization to the approved drug etoposide. Compound 1d is the first known small-molecule inhibitor for BRAT1, a master regulator of the DDR and DNA repair. Composition matters and methods of uses are within the scope of this disclosure.

Curcusone diterpenoids and uses thereof

The present disclosure provides the first asymmetric total synthesis and target identification of the curcusone natural products. The novel convergent synthesis is built upon a cheap and abundant chiral pool molecule (8) and features a thermal [3,3]-sigmatropic rearrangement and an FeCl3-promoted global hydrolysis/adol condensation cascade to rapidly construct the critical cycloheptadienone core. By performing chemoproteomics with the alkyne probe 37, we identified the previously undruggable oncogenic protein BRAT1 as a key cellular target of 1d. Furthermore, 1d inhibits BRAT1 in cancer cells, thereby reducing cancer cell migration, increasing susceptibility to DNA damage, and inducing chemosensitization to the approved drug etoposide. Compound 1d is the first known small-molecule inhibitor for BRAT1, a master regulator of the DDR and DNA repair. Composition matters and methods of uses are within the scope of this disclosure.